128263-66-1 Usage
Uses
Used in Pharmaceutical Research and Development:
4-(METHYLSULFONYLAMINO)BENZYLAMINEHYDROCHLORIDE is used as a research reagent for the synthesis and development of new drugs, given its potential biological activity and solubility properties.
Used in Antihistamine Development:
In the pharmaceutical industry, 4-(METHYLSULFONYLAMINO)BENZYLAMINEHYDROCHLORIDE is used as a precursor in the development of antihistamine medications, due to its potential to modulate histamine responses and alleviate allergic symptoms.
Used in Neurological and Psychiatric Treatment Research:
4-(METHYLSULFONYLAMINO)BENZYLAMINEHYDROCHLORIDE is utilized as a pharmaceutical intermediate in the research for treatments of neurological and psychiatric disorders, exploring its potential therapeutic effects on these conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 128263-66-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,8,2,6 and 3 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 128263-66:
(8*1)+(7*2)+(6*8)+(5*2)+(4*6)+(3*3)+(2*6)+(1*6)=131
131 % 10 = 1
So 128263-66-1 is a valid CAS Registry Number.
128263-66-1Relevant articles and documents
NOVEL COMPOUNDS, ISOMER THEREOF OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
-
Page/Page column 44, (2010/11/23)
This present invention relates to novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor (Vanilloid Receptor 1; VR1; TRPV1 )antagonist; and a pharmaceutical composition containing the same. The present invention
Derivatized alkanolamines as cardiovascular agents
-
, (2008/06/13)
Novel derivatized alkanolamines of the following structural formula STR1 are described as useful cardiovascular agents. Most especially described is their usefulness as cardiovascular agents exhibiting an antiarrhythmic effect. Said antiarrhythmic effect is of a combination Class II/Class III variety. Pharmaceutical formulations containing such compounds are also described.